Literature DB >> 22014620

Early development of social deficits in APP and APP-PS1 mice.

Susanna Pietropaolo1, Pauline Delage, Fanny Lebreton, Wim E Crusio, Yoon H Cho.   

Abstract

Mimicking relevant behavioral features of the human pathology is one of the most important challenges for animal models of neurological disorders including Alzheimer disease (AD). Indeed, the most popular genetic AD mouse lines bearing mutations of the amyloid precursor protein (APP) and presenilin 1 genes (PS1), often fail to present robust cognitive deficits or show them only at very advanced ages. It is therefore crucial to identify AD-like behavioral alterations which may reliably reflect the early stages of the pathology, thus permitting tests of more efficient early therapeutic interventions. Here, we demonstrated the very early expression of noncognitive AD-like symptoms, i.e., deficits in social interest, interaction and communication, in APP and APP-PS1 transgenic mice. Conversely, other noncognitive behaviors (sensori-motor gating) as well as cognitive abilities (spontaneous alternation) were unaltered in AD transgenics. Our data suggest that social deficits precede other neuropsychiatric and cognitive AD-like symptoms and can be employed as early markers of AD pathology in genetic mouse models. Copyright Â
© 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014620     DOI: 10.1016/j.neurobiolaging.2011.09.012

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  12 in total

Review 1.  Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.

Authors:  A Shepherd; S Tyebji; A J Hannan; E L Burrows
Journal:  J Mol Neurosci       Date:  2016-09-16       Impact factor: 3.444

2.  Xanthoceraside prevented synaptic loss and reversed learning-memory deficits in APP/PS1 transgenic mice.

Authors:  Ge Jin; Lin Zhu; Peng Liu; Qian Xu; Yue Qi; Xiaoyu Zhou; Jikai Xu; Xuefei Ji; Tianyan Chi; Libo Zou
Journal:  J Physiol Sci       Date:  2019-02-14       Impact factor: 2.781

Review 3.  Non-cognitive symptoms and related conditions in the Alzheimer's disease: a literature review.

Authors:  Francesco Raudino
Journal:  Neurol Sci       Date:  2013-03-31       Impact factor: 3.307

4.  Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice.

Authors:  John A Kennard; Fiona E Harrison
Journal:  Behav Brain Res       Date:  2014-02-05       Impact factor: 3.332

5.  Neuropathological and behavioral features of an APP/PS1/MAPT (6xTg) transgenic model of Alzheimer's disease.

Authors:  Sung Hyun Tag; Baeksun Kim; Jinhee Bae; Keun-A Chang; Heh-In Im
Journal:  Mol Brain       Date:  2022-06-08       Impact factor: 4.399

6.  Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease.

Authors:  Cyril Bories; Matthieu J Guitton; Carl Julien; Cyntia Tremblay; Milène Vandal; Meriem Msaid; Yves De Koninck; Frédéric Calon
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

7.  Sleep Physiology Alterations Precede Plethoric Phenotypic Changes in R6/1 Huntington's Disease Mice.

Authors:  Fanny Lebreton; Sebastien Cayzac; Susanna Pietropaolo; Yannick Jeantet; Yoon H Cho
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

8.  Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.

Authors:  Louise Ørum Olesen; Elena V Bouzinova; Maurizio Severino; Mithula Sivasaravanaparan; Jørgen Bo Hasselstrøm; Bente Finsen; Ove Wiborg
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

9.  Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis.

Authors:  Zhi-Yuan Zhang; Rolf Daniels; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2013-09-05       Impact factor: 5.310

10.  Icariin ameliorates neuropathological changes, TGF-β1 accumulation and behavioral deficits in a mouse model of cerebral amyloidosis.

Authors:  Zhi-Yuan Zhang; Chaoyun Li; Caroline Zug; Hermann J Schluesener
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.